Finance

Lists
Why is EVFM up 6,43%?
Dive Deeper
EVFM:OTCMKTS
Evofem Biosciences Inc
0,0074 $
+6,43%
(+0,00045) 1D
14 қаз., 12:11:09 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVFM...
Open
0,01 $
High
0,01 $
Low
0,01 $
Mkt. cap
691,14 м.
Avg. vol.
112,55 м.
Volume
10,27 мың
52-wk high
0,02 $
52-wk low
0,00 $
EPS
-0,14 $
Beta
-1,37
Shares outstanding
132,53 млн
No. of employees
29
Open
0,01 $
High
0,01 $
Low
0,01 $
Mkt. cap
691,14 м.
Avg. vol.
112,55 м.
Volume
10,27 мың
52-wk high
0,02 $
52-wk low
0,00 $
EPS
-0,14 $
Beta
-1,37
Shares outstanding
132,53 млн
No. of employees
29
News stories
From web sources and news partners
About Evofem Biosciences Inc
CEOSaundra Pelletier
Employees29
Founded2007
Headquarters-
SectorPharmaceutical industry
Websiteevofem.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
4,95 млн
9,56 млн
899,00 м.
2,63 млн
Cost of goods sold
905,00 м.
2,59 млн
410,00 м.
511,00 м.
Cost of revenue
905,00 м.
2,59 млн
410,00 м.
511,00 м.
Research and development expenses
469,00 м.
372,00 м.
517,00 м.
693,00 м.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,48 млн
3,16 млн
4,47 млн
3,90 млн
Operating expense
5,03 млн
3,62 млн
5,06 млн
4,61 млн
Total operating expenses
5,93 млн
6,22 млн
5,47 млн
5,12 млн
Operating income
-982,00 м.
3,34 млн
-4,57 млн
-2,49 млн
Other non operating income
-2,53 млн
2,08 млн
-162,00 м.
-5,76 млн
EBT including unusual items
-1,57 млн
2,79 млн
-5,47 млн
-11,04 млн
EBT excluding unusual items
-3,51 млн
2,79 млн
-5,47 млн
-8,84 млн
Income tax expense
-4,00 мың
-1,00 мың
-1,00 мың
-
Effective tax rate
0,25%
-0,04%
0,02%
-
Other operating expenses
-
-
-
-
Net income
-1,57 млн
2,79 млн
-5,46 млн
-11,04 млн
Net profit margin
-31,68%
29,16%
-607,90%
-419,14%
Earnings per share
-
-
-
-
Interest and investment income
3,00 мың
2,00 мың
2,00 мың
3,00 мың
Interest expense
-
-2,64 млн
-737,00 м.
-600,00 м.
Net interest expenses
3,00 мың
-2,63 млн
-735,00 м.
-597,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
-898,00 м.
3,44 млн
-4,49 млн
-2,47 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары